Abstract
The worldwide epidemic scale of Diabetes mellitus (DM) has been underestimated for a long time. Currently every 10 seconds one patient dies of diabetes-related pathologies. Given the high risk and prevalence of secondary complications as well as individual predisposition to target organ injury, DM is one of the best examples for the application of predictive diagnostics aimed at preventive measures and personalized treatment. Generally, there are three levels desirable for pre- and Diabetes care:
1st level: prediction of the predisposition early in childhood
2nd level: prediction of early/premature aging and pre-stages of Diabetes
3rd level: prediction of Diabetes-related complications - cardiovascular, neurodegenerative and cancer diseases frequently developed in Diabetics.
Predictive diagnosis is considered as the basis for targeted preventive measures and consequent development of individualized treatment approaches. Communication among the professionals e.g. healthcare providers, policy-makers, educators, obligatorily involved in the overall process to improve (pre)Diabetes care is of paramount importance.
Keywords: Diabetes mellitus, morbidity, &, mortality, cardiovascular / Cancer / Neurodegenrative complications, socioeconomical burden, healthcare, predictive diagnosis, preventive measures, personalized medicine, healthcare providers, policymakers
Current Diabetes Reviews
Title: Advanced Diabetes Care: Three Levels of Prediction, Prevention & Personalized Treatment
Volume: 6 Issue: 1
Author(s): Olga Golubnitschaja
Affiliation:
Keywords: Diabetes mellitus, morbidity, &, mortality, cardiovascular / Cancer / Neurodegenrative complications, socioeconomical burden, healthcare, predictive diagnosis, preventive measures, personalized medicine, healthcare providers, policymakers
Abstract: The worldwide epidemic scale of Diabetes mellitus (DM) has been underestimated for a long time. Currently every 10 seconds one patient dies of diabetes-related pathologies. Given the high risk and prevalence of secondary complications as well as individual predisposition to target organ injury, DM is one of the best examples for the application of predictive diagnostics aimed at preventive measures and personalized treatment. Generally, there are three levels desirable for pre- and Diabetes care:
1st level: prediction of the predisposition early in childhood
2nd level: prediction of early/premature aging and pre-stages of Diabetes
3rd level: prediction of Diabetes-related complications - cardiovascular, neurodegenerative and cancer diseases frequently developed in Diabetics.
Predictive diagnosis is considered as the basis for targeted preventive measures and consequent development of individualized treatment approaches. Communication among the professionals e.g. healthcare providers, policy-makers, educators, obligatorily involved in the overall process to improve (pre)Diabetes care is of paramount importance.
Export Options
About this article
Cite this article as:
Golubnitschaja Olga, Advanced Diabetes Care: Three Levels of Prediction, Prevention & Personalized Treatment, Current Diabetes Reviews 2010; 6 (1) . https://dx.doi.org/10.2174/157339910790442637
DOI https://dx.doi.org/10.2174/157339910790442637 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Oxidative Stress in the Pathogenesis/Treatment of Diabetes and its Complications
Current Nutrition & Food Science Myocardial Perfusion and Coronary Vasomotor Function: Emerging Role of PET Imaging
Vascular Disease Prevention (Discontinued) Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma
Current Cancer Drug Targets Poly(Ethylene Glycol)-block-Poly(ε-Caprolactone) Nanomicelles for the Solubilization and Enhancement of Antifungal Activity of Sertaconazole
Current Drug Delivery Mitochondrial Disorders in Adults
Current Molecular Medicine Cytokines as Therapeutic Targets to Reduce Cardiovascular Risk in Chronic Inflammation
Current Pharmaceutical Design Skeletal Muscle Insulin Resistance as a Precursor to Diabetes: Beyond Glucoregulation
Current Diabetes Reviews Effect of Vitamin D<sub>3</sub> on Lifespan in Caenorhabditis elegans
Current Aging Science Proteomics and Protein Analyses of Ovine and Caprine Body Fluids: Current Studies and Future Promises
Current Protein & Peptide Science Aliphatic and Aromatic Oxidations, Epoxidation and S-Oxidation of Prodrugs that Yield Active Drug Metabolites
Current Medicinal Chemistry A Review on Molecular Mechanism of Flavonoids as Antidiabetic Agents
Mini-Reviews in Medicinal Chemistry Knowledge and Awareness of Oral Manifestations of Diabetes Mellitus and Oral Health Assessment among Diabetes Mellitus Patients- A Cross Sectional Study
Current Diabetes Reviews MicroRNAs in the Diagnosis and Treatment of Unstable Angina
Current Topics in Medicinal Chemistry Chemoprevention with Phytonutrients and Microalgae Products in Chronic Inflammation and Colon Cancer
Current Pharmaceutical Design The Research Progress of DPP-4 Inhibitors
Mini-Reviews in Medicinal Chemistry Transcription Factors in Autoimmune Diseases
Current Pharmaceutical Design The Role of T and B Cells in Atherosclerosis: Potential Clinical Implications
Current Pharmaceutical Design Is there a Role for Antioxidants in the Treatment of Stable Angina?
Current Pharmaceutical Design Molecular Targets of Diabetic Cardiovascular Complications
Current Drug Targets Hepatic Effects of Duloxetine – III: Analysis of Hepatic Events Using External Data Sources
Current Drug Safety